药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Betacetylmethadol
Avasimibe
The serum concentration of Lurbinectedin can be decreased when it is combined with Avasimibe.
Betacetylmethadol
Midostaurin
The serum concentration of Lurbinectedin can be decreased when it is combined with Midostaurin.
Betacetylmethadol
Cenobamate
The serum concentration of Lurbinectedin can be decreased when it is combined with Cenobamate.
Betacetylmethadol
Metreleptin
The metabolism of Lurbinectedin can be increased when combined with Metreleptin.
Clostebol
Vibrio cholerae CVD 103-HgR strain live antigen
The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Plazomicin.
Clostebol
Magnesium
The serum concentration of Magnesium can be decreased when it is combined with Plazomicin.
Clostebol
Polymyxin B
The risk or severity of adverse effects can be increased when Plazomicin is combined with Polymyxin B.
Clostebol
(S)-Warfarin
The risk or severity of bleeding can be increased when Plazomicin is combined with (S)-Warfarin.
Clostebol
Tioclomarol
The risk or severity of bleeding can be increased when Plazomicin is combined with Tioclomarol.
Clostebol
Diphenadione
The risk or severity of bleeding can be increased when Plazomicin is combined with Diphenadione.
Clostebol
Clorindione
The risk or severity of bleeding can be increased when Plazomicin is combined with Clorindione.
Clostebol
Fluindione
The risk or severity of bleeding can be increased when Plazomicin is combined with Fluindione.
Clostebol
Ethyl biscoumacetate
The risk or severity of bleeding can be increased when Plazomicin is combined with Ethyl biscoumacetate.
Clostebol
(R)-warfarin
The risk or severity of bleeding can be increased when Plazomicin is combined with (R)-warfarin.
Clostebol
Coumarin
The risk or severity of bleeding can be increased when Plazomicin is combined with Coumarin.
Clostebol
4-hydroxycoumarin
The risk or severity of bleeding can be increased when Plazomicin is combined with 4-hydroxycoumarin.
Clostebol
Canrenone
Canrenone may increase the excretion rate of Plazomicin which could result in a lower serum level and potentially a reduction in efficacy.
Clostebol
Canrenoic acid
Canrenoic acid may increase the excretion rate of Plazomicin which could result in a lower serum level and potentially a reduction in efficacy.
Clostebol
Potassium
Potassium may increase the excretion rate of Plazomicin which could result in a lower serum level and potentially a reduction in efficacy.
Clostebol
Bromotheophylline
Bromotheophylline may increase the excretion rate of Plazomicin which could result in a lower serum level and potentially a reduction in efficacy.